TVGN - צמיחת מכירות משנה לשנה ב-12 החודשים האחרונים Tevogen Bio Inc.

Tevogen Bio Holdings (TVGN) develops scalable cell-based treatment methods for infections, ensuring high profitability with low costs. The rolling 12-month sales growth rate compared to the previous year visualizes the pace of business expansion, where 0.00 captures the magnitude of this parameter. Future prospects depend on the success of clinical trials for T-cell therapies, while the environmental footprint is limited solely to laboratory control.
Tevogen Bio (TVGN) - פילוחי מדדים ודוחות פיננסיים

Revenue dynamics for Tevogen Bio Holdings demonstrate the resilience of a business model based on efficient outsourcing of cellular platforms while maintaining full control over intellectual property. By analyzing relative sales growth over a 12-month period compared to the previous year, an investor assesses the TTM aggregate revenue, which allows for the filtering of short-term volatility and the identification of the company's real expansion vector, avoiding overpayment for temporary market spikes.